Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease

An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology

(2012) Christian Wider et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease

(2011) N. I. Bohnen et al.   BRAIN

White matter lesions in Parkinson disease

(2011) Nicolaas I. Bohnen et al.   Nature Reviews Neurology

Hippocampal and ventricular changes in Parkinson's disease mild cognitive impairment

(2011) Liana Apostolova et al.   NEUROBIOLOGY OF AGING

Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid

(2010) Audrey Gabelle et al.   BRAIN RESEARCH

Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42

(2010) Anders M. Fjell et al.   CEREBRAL CORTEX

The age-related white matter changes scale correlates with cognitive impairment

(2010) Y. Xiong et al.   EUROPEAN JOURNAL OF NEUROLOGY

CSF amyloid  38 as a novel diagnostic marker for dementia with Lewy bodies

(2010) E. Mulugeta et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study

(2010) Duygu Tosun et al.   NEUROBIOLOGY OF AGING

Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline

(2010) Yi-Yu Chou et al.   NEUROBIOLOGY OF AGING

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

(2010) Liana G. Apostolova et al.   NEUROBIOLOGY OF AGING

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Decreased cerebrospinal fluid Aβ42correlates with brain atrophy in cognitively normal elderly

(2009) Anne M. Fagan et al.   ANNALS OF NEUROLOGY

The progression of pathology in Parkinson's disease

(2009) Glenda Margaret Halliday et al.   Annals of the New York Academy of Sciences

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study

(2009) Martin Wilhelm Kurz et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

(2009) G Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurochemical biomarkers in the differential diagnosis of movement disorders

(2009) Brit Mollenhauer et al.   MOVEMENT DISORDERS

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

(2009) Yaroslau Compta et al.   MOVEMENT DISORDERS

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease

(2009) Turi O. Dalaker et al.   NEUROIMAGE

In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia

(2009) M. A. Burack et al.   NEUROLOGY

Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease

(2008) Yi-Yu Chou et al.   NEUROIMAGE

Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study

(2008) D. Aarsland et al.   NEUROLOGY